English

BIOTELEMETRY, INC.

EDGAR

BEAT Quarterly report (10-Q) · filed 2020-10-29

150 filing records in this dataset, filed from 2013-04-22 to 2020-10-29. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

115 million USD

2020 Q3 · USD

Exact inputs and evidence

Revenue: 114655000 USD Source

Operating margin

10.37%

2020 Q3 · %

Exact inputs and evidence

Operating Income: 11888000 USD Source
Revenue: 114655000 USD Source

Operating cash flow

21.9 million USD

2020 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 91434000 USD Source
Operating Cash Flow: 69545000 USD Source

Free cash flow

11.1 million USD

2020 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 91434000 USD Source
Operating Cash Flow: 69545000 USD Source
Capital Expenditure: 27877000 USD Source
Capital Expenditure: 17110000 USD Source

Cash and cash equivalents: 90.2 million USD 2020-09-30 Source
Exact value

90229000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 34.3 million shares 2020-09-30 Source
Exact value

34258980 shares

Reported share-count change

0.79% · 268 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

33991107 shares · 2019-09-30· Source
34258980 shares · 2020-09-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2020-10-29.

Financial data available through: 2019-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2019-12-31
Operating income: 8 of 11 periods available· newest 2019-12-31
Net income: 3 of 11 periods available· newest 2017-12-31
Operating cash flow: 8 of 11 periods available· newest 2019-12-31
Capital expenditure: 8 of 11 periods available· newest 2019-12-31
Total assets: 6 of 11 periods available· newest 2019-12-31
Total liabilities: 6 of 11 periods available· newest 2019-12-31
Current assets: 6 of 11 periods available· newest 2019-12-31
Current liabilities: 6 of 11 periods available· newest 2019-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2019-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2019-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+9.9%

Prior period

USD 399.47 million

2018-01-01 – 2018-12-31
Current period

USD 439.11 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

439107000 − 399472000 = 39635000 USD

399472000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
439107000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOTELEMETRY, INC. · 2019-12-31 BIOTELEMETRY, INC. (edgar:1574774) Year-over-year change in Revenue: 39635000 USD Concept: fundies:Revenue Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 439107000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#2660007 Filing: 000157477420000032 Input fundies:Revenue: 399472000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#2684988 Filing: 000157477420000032
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-7.1%

Prior period

USD 72.75 million

2018-01-01 – 2018-12-31
Current period

USD 67.55 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

67550000 − 72746000 = -5196000 USD

72746000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
67550000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOTELEMETRY, INC. · 2019-12-31 BIOTELEMETRY, INC. (edgar:1574774) Year-over-year change in Operating cash flow: -5196000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 67550000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1252727 Filing: 000157477420000032 Input fundies:OperatingCashFlow: 72746000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1253711 Filing: 000157477420000032
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+24.6%

Prior period

USD 24.64 million

2018-01-01 – 2018-12-31
Current period

USD 30.71 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

30707000 − 24637000 = 6070000 USD

24637000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
30707000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIOTELEMETRY, INC. · 2019-12-31 BIOTELEMETRY, INC. (edgar:1574774) Year-over-year change in Capital expenditure: 6070000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 30707000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1260091 Filing: 000157477420000032 Input fundies:CapitalExpenditure: 24637000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1260992 Filing: 000157477420000032
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2019-01-01 – 2019-12-31

Revenue USD 439.11 million 100% of revenue
Cost of revenue USD 164.83 million 38% of revenue
Operating expenses USD 221.52 million 50% of revenue
Operating income USD 52.75 million 12% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow USD 67.55 million 15% of revenue
Capital expenditure USD 30.71 million 7% of revenue
Free cash flow Derived USD 36.84 million 8.4% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2011 Not shown: operating income or net income is not reported.
2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.
2015 95%
2016 Net income was higher than operating income, so the split is not drawn.
2017 Operating loss: operating costs were 101% of revenue.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2011 2011-01-01 – 2011-12-31	119022000	180344000 Derived	-61322000	Unavailable	Unavailable	1076000 Derived	Source 2011-01-01 – 2011-12-31: 119022000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -61322000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 5030000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 3954000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	111494000	124653000 Derived	-13159000	Unavailable	Unavailable	-219000 Derived	Source 2012-01-01 – 2012-12-31: 111494000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -13159000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 5743000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 5962000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	129501000	136382000 Derived	-6881000	Unavailable	Unavailable	3090000 Derived	Source 2013-01-01 – 2013-12-31: 129501000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -6881000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 11259000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 8169000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	178513000	168995000 Derived	9518000	2090000 Derived	7428000	750000 Derived	Source 2015-01-01 – 2015-12-31: 178513000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: 9518000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: 7428000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 14350000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 13600000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	208332000	190320000 Derived	18012000	-35425000 Derived	53437000	27952000 Derived	Source 2016-01-01 – 2016-12-31: 208332000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 18012000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 53437000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 38851000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 10899000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	286776000	288539000 Derived	-1763000	14193000 Derived	-15956000	10085000 Derived	Source 2017-01-01 – 2017-12-31: 286776000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -1763000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -15956000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 23782000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 13697000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	399472000	349658000 Derived	49814000	Unavailable	Unavailable	48109000 Derived	Source 2018-01-01 – 2018-12-31: 399472000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 49814000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 72746000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 24637000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	439107000	386356000 Derived	52751000	Unavailable	Unavailable	36843000 Derived	Source 2019-01-01 – 2019-12-31: 439107000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 52751000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 67550000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 30707000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 439.1M 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Revenue	119022000	Revenue: 119022000 Open source
20122012-12-31	Revenue	111494000	Revenue: 111494000 Open source
20132013-12-31	Revenue	129501000	Revenue: 129501000 Open source
20152015-12-31	Revenue	178513000	Revenue: 178513000 Open source
20162016-12-31	Revenue	208332000	Revenue: 208332000 Open source
20172017-12-31	Revenue	286776000	Revenue: 286776000 Open source
20182018-12-31	Revenue	399472000	Revenue: 399472000 Open source
20192019-12-31	Revenue	439107000	Revenue: 439107000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

9.9% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Year over year	No prior comparable period	Revenue: 119022000 Open source
20122012-12-31	Year over year	-6.3%	Revenue: 111494000 Open source Revenue: 119022000 Open source
20132013-12-31	Year over year	16.2%	Revenue: 129501000 Open source Revenue: 111494000 Open source
20152015-12-31	Year over year	No prior comparable period	Revenue: 178513000 Open source
20162016-12-31	Year over year	16.7%	Revenue: 208332000 Open source Revenue: 178513000 Open source
20172017-12-31	Year over year	37.7%	Revenue: 286776000 Open source Revenue: 208332000 Open source
20182018-12-31	Year over year	39.3%	Revenue: 399472000 Open source Revenue: 286776000 Open source
20192019-12-31	Year over year	9.9%	Revenue: 439107000 Open source Revenue: 399472000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 12% 2019

Net margin -5.6% 2017

Free cash flow margin 8.4% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Operating margin	-51.5%	Operating Income: -61322000 Open source Revenue: 119022000 Open source
20122012-12-31	Operating margin	-11.8%	Operating Income: -13159000 Open source Revenue: 111494000 Open source
20132013-12-31	Operating margin	-5.3%	Operating Income: -6881000 Open source Revenue: 129501000 Open source
20152015-12-31	Operating margin	5.3%	Operating Income: 9518000 Open source Revenue: 178513000 Open source
20162016-12-31	Operating margin	8.6%	Operating Income: 18012000 Open source Revenue: 208332000 Open source
20172017-12-31	Operating margin	-0.6%	Operating Income: -1763000 Open source Revenue: 286776000 Open source
20182018-12-31	Operating margin	12.5%	Operating Income: 49814000 Open source Revenue: 399472000 Open source
20192019-12-31	Operating margin	12%	Operating Income: 52751000 Open source Revenue: 439107000 Open source
2011-12-31	Net margin	Not reported	Revenue: 119022000 Open source
2012-12-31	Net margin	Not reported	Revenue: 111494000 Open source
2013-12-31	Net margin	Not reported	Revenue: 129501000 Open source
20152015-12-31	Net margin	4.2%	Net Income: 7428000 Open source Revenue: 178513000 Open source
20162016-12-31	Net margin	25.6%	Net Income: 53437000 Open source Revenue: 208332000 Open source
20172017-12-31	Net margin	-5.6%	Net Income: -15956000 Open source Revenue: 286776000 Open source
2018-12-31	Net margin	Not reported	Revenue: 399472000 Open source
2019-12-31	Net margin	Not reported	Revenue: 439107000 Open source
20112011-12-31	Free cash flow margin	0.9%	Revenue: 119022000 Open source Operating Cash Flow: 5030000 Open source Capital Expenditure: 3954000 Open source
20122012-12-31	Free cash flow margin	-0.2%	Revenue: 111494000 Open source Operating Cash Flow: 5743000 Open source Capital Expenditure: 5962000 Open source
20132013-12-31	Free cash flow margin	2.4%	Revenue: 129501000 Open source Operating Cash Flow: 11259000 Open source Capital Expenditure: 8169000 Open source
20152015-12-31	Free cash flow margin	0.4%	Revenue: 178513000 Open source Operating Cash Flow: 14350000 Open source Capital Expenditure: 13600000 Open source
20162016-12-31	Free cash flow margin	13.4%	Revenue: 208332000 Open source Operating Cash Flow: 38851000 Open source Capital Expenditure: 10899000 Open source
20172017-12-31	Free cash flow margin	3.5%	Revenue: 286776000 Open source Operating Cash Flow: 23782000 Open source Capital Expenditure: 13697000 Open source
20182018-12-31	Free cash flow margin	12%	Revenue: 399472000 Open source Operating Cash Flow: 72746000 Open source Capital Expenditure: 24637000 Open source
20192019-12-31	Free cash flow margin	8.4%	Revenue: 439107000 Open source Operating Cash Flow: 67550000 Open source Capital Expenditure: 30707000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 67.6M 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Operating cash flow	5030000	Operating Cash Flow: 5030000 Open source
20122012-12-31	Operating cash flow	5743000	Operating Cash Flow: 5743000 Open source
20132013-12-31	Operating cash flow	11259000	Operating Cash Flow: 11259000 Open source
20152015-12-31	Operating cash flow	14350000	Operating Cash Flow: 14350000 Open source
20162016-12-31	Operating cash flow	38851000	Operating Cash Flow: 38851000 Open source
20172017-12-31	Operating cash flow	23782000	Operating Cash Flow: 23782000 Open source
20182018-12-31	Operating cash flow	72746000	Operating Cash Flow: 72746000 Open source
20192019-12-31	Operating cash flow	67550000	Operating Cash Flow: 67550000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 36.8M 2019

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Free cash flow	1076000	Operating Cash Flow: 5030000 Open source Capital Expenditure: 3954000 Open source
20122012-12-31	Free cash flow	-219000	Operating Cash Flow: 5743000 Open source Capital Expenditure: 5962000 Open source
20132013-12-31	Free cash flow	3090000	Operating Cash Flow: 11259000 Open source Capital Expenditure: 8169000 Open source
20152015-12-31	Free cash flow	750000	Operating Cash Flow: 14350000 Open source Capital Expenditure: 13600000 Open source
20162016-12-31	Free cash flow	27952000	Operating Cash Flow: 38851000 Open source Capital Expenditure: 10899000 Open source
20172017-12-31	Free cash flow	10085000	Operating Cash Flow: 23782000 Open source Capital Expenditure: 13697000 Open source
20182018-12-31	Free cash flow	48109000	Operating Cash Flow: 72746000 Open source Capital Expenditure: 24637000 Open source
20192019-12-31	Free cash flow	36843000	Operating Cash Flow: 67550000 Open source Capital Expenditure: 30707000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

46.5% 2019

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2011-12-31	Liabilities / assets	Not reported	No source recorded
20122012-12-31	Liabilities / assets	22.2%	Total Liabilities: 20012000 Open source Total Assets: 90010000 Open source
20132013-12-31	Liabilities / assets	23.7%	Total Liabilities: 20717000 Open source Total Assets: 87546000 Open source
2015-12-31	Liabilities / assets	Not reported	No source recorded
20162016-12-31	Liabilities / assets	30.2%	Total Liabilities: 60070000 Open source Total Assets: 198984000 Open source
20172017-12-31	Liabilities / assets	52.4%	Total Liabilities: 274859000 Open source Total Assets: 524562000 Open source
20182018-12-31	Liabilities / assets	47.1%	Total Liabilities: 276316000 Open source Total Assets: 586801000 Open source
20192019-12-31	Liabilities / assets	46.5%	Total Liabilities: 318803000 Open source Total Assets: 685720000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.02× 2019

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2011-12-31	Current assets / current liabilities	Not reported	No source recorded
20122012-12-31	Current assets / current liabilities	2.35×	Current Assets: 43422000 Open source Current Liabilities: 18490000 Open source
20132013-12-31	Current assets / current liabilities	2.32×	Current Assets: 44255000 Open source Current Liabilities: 19040000 Open source
2015-12-31	Current assets / current liabilities	Not reported	No source recorded
20162016-12-31	Current assets / current liabilities	1.89×	Current Assets: 59560000 Open source Current Liabilities: 31507000 Open source
20172017-12-31	Current assets / current liabilities	1.77×	Current Assets: 90108000 Open source Current Liabilities: 50955000 Open source
20182018-12-31	Current assets / current liabilities	2.96×	Current Assets: 146660000 Open source Current Liabilities: 49623000 Open source
20192019-12-31	Current assets / current liabilities	3.02×	Current Assets: 168333000 Open source Current Liabilities: 55754000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2011 2011-01-01 – 2011-12-31	Unavailable Not reported for this period.	USD 5.03 million Exact value Exact value: 5030000 USD 2011-01-01 – 2011-12-31: 5030000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTELEMETRY, INC. · 2011-12-31 BIOTELEMETRY, INC. (edgar:1574774) Operating Cash Flow: 5030000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5030000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#893179 Filing: 000104746914001401 The citation records this snapshot. The page link may show a newer release later.	USD 3.95 million Exact value Exact value: 3954000 USD 2011-01-01 – 2011-12-31: 3954000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTELEMETRY, INC. · 2011-12-31 BIOTELEMETRY, INC. (edgar:1574774) Capital Expenditure: 3954000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3954000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#893668 Filing: 000104746914001401 The citation records this snapshot. The page link may show a newer release later.	USD 1.08 million Calculation and evidence 5030000 − 3954000 USD Exact free cash flow: 1076000 USD 2011-01-01 – 2011-12-31: 5030000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 3954000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTELEMETRY, INC. · 2011-12-31 BIOTELEMETRY, INC. (edgar:1574774) Free cash flow: 1076000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5030000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#893179 Filing: 000104746914001401 Input fundies:CapitalExpenditure: 3954000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#893668 Filing: 000104746914001401 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	Unavailable Not reported for this period.	USD 5.74 million Exact value Exact value: 5743000 USD 2012-01-01 – 2012-12-31: 5743000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTELEMETRY, INC. · 2012-12-31 BIOTELEMETRY, INC. (edgar:1574774) Operating Cash Flow: 5743000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5743000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#889104 Filing: 000104746914001401 The citation records this snapshot. The page link may show a newer release later.	USD 5.96 million Exact value Exact value: 5962000 USD 2012-01-01 – 2012-12-31: 5962000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTELEMETRY, INC. · 2012-12-31 BIOTELEMETRY, INC. (edgar:1574774) Capital Expenditure: 5962000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5962000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#889497 Filing: 000104746914001401 The citation records this snapshot. The page link may show a newer release later.	−USD 219,000 Calculation and evidence 5743000 − 5962000 USD Exact free cash flow: -219000 USD 2012-01-01 – 2012-12-31: 5743000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 5962000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTELEMETRY, INC. · 2012-12-31 BIOTELEMETRY, INC. (edgar:1574774) Free cash flow: -219000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5743000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#889104 Filing: 000104746914001401 Input fundies:CapitalExpenditure: 5962000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#889497 Filing: 000104746914001401 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	Unavailable Not reported for this period.	USD 11.26 million Exact value Exact value: 11259000 USD 2013-01-01 – 2013-12-31: 11259000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTELEMETRY, INC. · 2013-12-31 BIOTELEMETRY, INC. (edgar:1574774) Operating Cash Flow: 11259000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 11259000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#894648 Filing: 000104746914001401 The citation records this snapshot. The page link may show a newer release later.	USD 8.17 million Exact value Exact value: 8169000 USD 2013-01-01 – 2013-12-31: 8169000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTELEMETRY, INC. · 2013-12-31 BIOTELEMETRY, INC. (edgar:1574774) Capital Expenditure: 8169000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8169000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#1399990 Filing: 000104746914001401 The citation records this snapshot. The page link may show a newer release later.	USD 3.09 million Calculation and evidence 11259000 − 8169000 USD Exact free cash flow: 3090000 USD 2013-01-01 – 2013-12-31: 11259000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 8169000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTELEMETRY, INC. · 2013-12-31 BIOTELEMETRY, INC. (edgar:1574774) Free cash flow: 3090000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 11259000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#894648 Filing: 000104746914001401 Input fundies:CapitalExpenditure: 8169000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000104746914001401/beat-20131231.xml#1399990 Filing: 000104746914001401 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	USD 7.43 million Exact value Exact value: 7428000 USD 2015-01-01 – 2015-12-31: 7428000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOTELEMETRY, INC. · 2015-12-31 BIOTELEMETRY, INC. (edgar:1574774) Net Income: 7428000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7428000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477418000014/beat-20171231.xml#396061 Filing: 000157477418000014 The citation records this snapshot. The page link may show a newer release later.	USD 14.35 million Exact value Exact value: 14350000 USD 2015-01-01 – 2015-12-31: 14350000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTELEMETRY, INC. · 2015-12-31 BIOTELEMETRY, INC. (edgar:1574774) Operating Cash Flow: 14350000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 14350000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477418000014/beat-20171231.xml#395308 Filing: 000157477418000014 The citation records this snapshot. The page link may show a newer release later.	USD 13.6 million Exact value Exact value: 13600000 USD 2015-01-01 – 2015-12-31: 13600000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTELEMETRY, INC. · 2015-12-31 BIOTELEMETRY, INC. (edgar:1574774) Capital Expenditure: 13600000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13600000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477418000014/beat-20171231.xml#417135 Filing: 000157477418000014 The citation records this snapshot. The page link may show a newer release later.	USD 750,000 Calculation and evidence 14350000 − 13600000 USD Exact free cash flow: 750000 USD 2015-01-01 – 2015-12-31: 14350000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 13600000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTELEMETRY, INC. · 2015-12-31 BIOTELEMETRY, INC. (edgar:1574774) Free cash flow: 750000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 14350000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477418000014/beat-20171231.xml#395308 Filing: 000157477418000014 Input fundies:CapitalExpenditure: 13600000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477418000014/beat-20171231.xml#417135 Filing: 000157477418000014 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	USD 53.44 million Exact value Exact value: 53437000 USD 2016-01-01 – 2016-12-31: 53437000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOTELEMETRY, INC. · 2016-12-31 BIOTELEMETRY, INC. (edgar:1574774) Net Income: 53437000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 53437000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477418000014/beat-20171231.xml#396213 Filing: 000157477418000014 The citation records this snapshot. The page link may show a newer release later.	USD 38.85 million Exact value Exact value: 38851000 USD 2016-01-01 – 2016-12-31: 38851000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTELEMETRY, INC. · 2016-12-31 BIOTELEMETRY, INC. (edgar:1574774) Operating Cash Flow: 38851000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 38851000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477419000018/beat-20181231.xml#359890 Filing: 000157477419000018 The citation records this snapshot. The page link may show a newer release later.	USD 10.9 million Exact value Exact value: 10899000 USD 2016-01-01 – 2016-12-31: 10899000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTELEMETRY, INC. · 2016-12-31 BIOTELEMETRY, INC. (edgar:1574774) Capital Expenditure: 10899000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10899000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477419000018/beat-20181231.xml#383284 Filing: 000157477419000018 The citation records this snapshot. The page link may show a newer release later.	USD 27.95 million Calculation and evidence 38851000 − 10899000 USD Exact free cash flow: 27952000 USD 2016-01-01 – 2016-12-31: 38851000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 10899000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTELEMETRY, INC. · 2016-12-31 BIOTELEMETRY, INC. (edgar:1574774) Free cash flow: 27952000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 38851000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477419000018/beat-20181231.xml#359890 Filing: 000157477419000018 Input fundies:CapitalExpenditure: 10899000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477419000018/beat-20181231.xml#383284 Filing: 000157477419000018 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 15.96 million Exact value Exact value: -15956000 USD 2017-01-01 – 2017-12-31: -15956000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOTELEMETRY, INC. · 2017-12-31 BIOTELEMETRY, INC. (edgar:1574774) Net Income: -15956000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15956000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477418000014/beat-20171231.xml#396366 Filing: 000157477418000014 The citation records this snapshot. The page link may show a newer release later.	USD 23.78 million Exact value Exact value: 23782000 USD 2017-01-01 – 2017-12-31: 23782000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTELEMETRY, INC. · 2017-12-31 BIOTELEMETRY, INC. (edgar:1574774) Operating Cash Flow: 23782000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 23782000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1254695 Filing: 000157477420000032 The citation records this snapshot. The page link may show a newer release later.	USD 13.7 million Exact value Exact value: 13697000 USD 2017-01-01 – 2017-12-31: 13697000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTELEMETRY, INC. · 2017-12-31 BIOTELEMETRY, INC. (edgar:1574774) Capital Expenditure: 13697000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13697000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1261893 Filing: 000157477420000032 The citation records this snapshot. The page link may show a newer release later.	USD 10.09 million Calculation and evidence 23782000 − 13697000 USD Exact free cash flow: 10085000 USD 2017-01-01 – 2017-12-31: 23782000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 13697000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTELEMETRY, INC. · 2017-12-31 BIOTELEMETRY, INC. (edgar:1574774) Free cash flow: 10085000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 23782000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1254695 Filing: 000157477420000032 Input fundies:CapitalExpenditure: 13697000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1261893 Filing: 000157477420000032 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	Unavailable Not reported for this period.	USD 72.75 million Exact value Exact value: 72746000 USD 2018-01-01 – 2018-12-31: 72746000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTELEMETRY, INC. · 2018-12-31 BIOTELEMETRY, INC. (edgar:1574774) Operating Cash Flow: 72746000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 72746000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1253711 Filing: 000157477420000032 The citation records this snapshot. The page link may show a newer release later.	USD 24.64 million Exact value Exact value: 24637000 USD 2018-01-01 – 2018-12-31: 24637000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTELEMETRY, INC. · 2018-12-31 BIOTELEMETRY, INC. (edgar:1574774) Capital Expenditure: 24637000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 24637000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1260992 Filing: 000157477420000032 The citation records this snapshot. The page link may show a newer release later.	USD 48.11 million Calculation and evidence 72746000 − 24637000 USD Exact free cash flow: 48109000 USD 2018-01-01 – 2018-12-31: 72746000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 24637000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTELEMETRY, INC. · 2018-12-31 BIOTELEMETRY, INC. (edgar:1574774) Free cash flow: 48109000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 72746000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1253711 Filing: 000157477420000032 Input fundies:CapitalExpenditure: 24637000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1260992 Filing: 000157477420000032 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	Unavailable Not reported for this period.	USD 67.55 million Exact value Exact value: 67550000 USD 2019-01-01 – 2019-12-31: 67550000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTELEMETRY, INC. · 2019-12-31 BIOTELEMETRY, INC. (edgar:1574774) Operating Cash Flow: 67550000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 67550000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1252727 Filing: 000157477420000032 The citation records this snapshot. The page link may show a newer release later.	USD 30.71 million Exact value Exact value: 30707000 USD 2019-01-01 – 2019-12-31: 30707000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTELEMETRY, INC. · 2019-12-31 BIOTELEMETRY, INC. (edgar:1574774) Capital Expenditure: 30707000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 30707000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1260091 Filing: 000157477420000032 The citation records this snapshot. The page link may show a newer release later.	USD 36.84 million Calculation and evidence 67550000 − 30707000 USD Exact free cash flow: 36843000 USD 2019-01-01 – 2019-12-31: 67550000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 30707000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTELEMETRY, INC. · 2019-12-31 BIOTELEMETRY, INC. (edgar:1574774) Free cash flow: 36843000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574774?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 67550000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1252727 Filing: 000157477420000032 Input fundies:CapitalExpenditure: 30707000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574774/000157477420000032/beat12311910-k.htm#1260091 Filing: 000157477420000032 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

150 filings · 4,457 latest values · 4,457 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001574774, 1574774, BEAT, edgar:1574774

Also known as BIOTELEMETRY, INC., BioTelemetry, Inc.

BIOTELEMETRY, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Operating cash flow

Capital expenditure

Where revenue goes

2019 2019-01-01 – 2019-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation